scholarly article | Q13442814 |
P50 | author | Leslie S Kersun | Q88337265 |
P2093 | author name string | Kathleen E Sullivan | |
Abbas F Jawad | |||
Anne Reilly | |||
Jean Boyer | |||
Kenyetta McDonald | |||
Eline Luning Prak | |||
P2860 | cites work | Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen | Q24672799 |
After chemotherapy, functional humoral response capacity is restored before complete restoration of lymphoid compartments | Q57892192 | ||
Incidence of childhood leukaemia and non-Hodgkinʼs lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990–1999 | Q63604269 | ||
Doxorubicin and daunorubicin modulation of macrophages, T and B lymphocytes (anthracycline lymphocyte modulation) | Q72084739 | ||
Molecular genetics of human leukemia | Q77430007 | ||
The mechanisms of Ara-C-induced apoptosis of resting B-chronic lymphocytic leukemia cells | Q79833253 | ||
A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): factors associated with B lymphocyte recovery | Q80564566 | ||
Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience | Q80587777 | ||
Pediatric acute myeloid leukemia: international progress and future directions | Q81521475 | ||
Remission induction chemotherapy induces in vivo caspase-dependent apoptosis in bone marrow acute myeloid leukemia blast cells and spares lymphocytes | Q83008359 | ||
Functional subsets of memory T cells identified by CCR7 expression | Q28141547 | ||
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions | Q28146072 | ||
Lineage relationship and protective immunity of memory CD8 T cell subsets | Q28206693 | ||
Anthracyclines trigger apoptosis of both G0-G1 and cycling peripheral blood lymphocytes and induce massive deletion of mature T and B cells | Q28376845 | ||
Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response | Q28590125 | ||
Occurrence of myeloproliferative disorder in patients with Noonan syndrome | Q33499657 | ||
Molecular genetics of acute myeloid leukaemia | Q34252834 | ||
Altered IL-7Ralpha expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses. | Q34546812 | ||
Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial. | Q34568939 | ||
Bloom's syndrome. XX. The first 100 cancers | Q34738495 | ||
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Q35018548 | ||
Similarities and differences in CD4+ and CD8+ effector and memory T cell generation | Q35207085 | ||
Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia | Q35218212 | ||
Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation? | Q35553553 | ||
Central memory CD8+ T cells appear to have a shorter lifespan and reduced abundance as a function of HIV disease progression. | Q36925272 | ||
Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children | Q37040671 | ||
Respiratory syncytial virus infections in children with acute myeloid leukemia: a report from the Children's Oncology Group | Q37306772 | ||
Prognostic factors in pediatric acute myeloid leukemia | Q37774916 | ||
Neurofibromatosis and childhood leukemia | Q39601753 | ||
Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies | Q40146905 | ||
Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. | Q40471970 | ||
Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93 | Q40547323 | ||
Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MCR Childhood Leukaemia Working Party | Q40800105 | ||
Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells | Q41326662 | ||
Molecular biology of acute myeloid leukemia. | Q41358269 | ||
Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire | Q41505077 | ||
Anthracyclines in haematology: preclinical studies, toxicity and delivery systems | Q41711763 | ||
Rapid turnover of effector-memory CD4(+) T cells in healthy humans | Q42134878 | ||
Phenotypic and functional separation of memory and effector human CD8+ T cells | Q42951823 | ||
Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy | Q43792143 | ||
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma | Q43864036 | ||
The efficacy of influenza vaccination in a pediatric oncology population. | Q44436455 | ||
Cytarabine: cytocidal effect on normal and leukemic lymphocytes. Synergism with x rays and comparison with mechlorethamine | Q44503661 | ||
Direct measurement of T cell subset kinetics in vivo in elderly men and women | Q44987469 | ||
CD31 (PECAM-1) is a marker of recent thymic emigrants among CD4+ T-cells, but not CD8+ T-cells or gammadelta T-cells, in HIV patients responding to ART. | Q45219923 | ||
Quantitation of human influenza virus-specific cytotoxic T lymphocytes: correlation of cytotoxicity and increased numbers of IFN-gamma producing CD8+ T cells | Q45779006 | ||
Age- and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries | Q47442393 | ||
Extensive replicative capacity of human central memory T cells | Q47579128 | ||
Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system | Q47756393 | ||
Trends in leukemia incidence and survival in the United States (1973–1998) | Q50718276 | ||
A prospective study of influenza vaccination and a comparison of immunologic parameters in children and adults with chromosome 22q11.2 deletion syndrome (digeorge syndrome/velocardiofacial syndrome). | Q51168850 | ||
Heterogeneity of the circulating human CD4+ T cell population. Further evidence that the CD4+CD45RA-CD27- T cell subset contains specialized primed T cells. | Q52054952 | ||
In utero rearrangements in the trithorax-related oncogene in infant leukaemias. | Q52225004 | ||
Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma | Q53293730 | ||
Cancer incidence in persons with Fanconi anemia. | Q55036178 | ||
P433 | issue | 1 | |
P921 | main subject | chemotherapy | Q974135 |
P304 | page(s) | 46-53 | |
P577 | publication date | 2013-01-01 | |
P1433 | published in | Journal of Pediatric Hematology/Oncology | Q15761808 |
P1476 | title | Immunologic consequences of chemotherapy for acute myeloid leukemia | |
P478 | volume | 35 |
Q41593302 | An adjuvanted whole cell vaccine as post-remission immunotherapy for acute leukemia. |
Q33892358 | Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy. |
Q90616541 | Noninvasive Detection of Antibodies to Human T-Cell Lymphotropic Virus Types 1 and 2 by Use of Oral Fluid |
Q36630470 | Protecting pediatric oncology patients from influenza |
Search more.